Paper40314877
Lactic acid metabolism: gynecological cancer's Achilles' heel.
Zhang T and 7 others. Discov Oncol, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Lactic acid metabolism: gynecological cancer's Achilles' heel. Papers, record 40314877. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40314877
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2021JJ50070 | Natural Science Foundation of Hunan Province | PubMed | ||
| 2023JJ41066 | Natural Science Foundation of Hunan Province | PubMed | ||
| 22A0317 | Education Department of Hunan Province | PubMed | ||
| 82303246 | National Natural Science Foundation of China | PubMed |
Source PubMed
References189
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37705596 | Hybrid computational modeling highlights reverse warburg effect in breast cancer-associated fibroblasts. | Comput Struct Biotechnol J | 2023 | https://conductscience.org/library/papers/37705596 | PubMed |
| 2 | 34744727 | Lactate Dehydrogenase A or B Knockdown Reduces Lactate Production and Inhibits Breast Cancer Cell Motility in vitro. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34744727 | PubMed |
| 3 | 29409830 | HIF1-alpha Regulates Acinar Cell Function and Response to Injury in Mouse Pancreas. | Gastroenterology | 2018 | https://conductscience.org/library/papers/29409830 | PubMed |
| 4 | 29151072 | The lactate receptor (HCAR1/GPR81) contributes to doxorubicin chemoresistance via ABCB1 transporter up-regulation in human cervical cancer HeLa cells. | J Physiol Pharmacol | 2017 | https://conductscience.org/library/papers/29151072 | PubMed |
| 5 | 21680735 | Transport activity of the high-affinity monocarboxylate transporter MCT2 is enhanced by extracellular carbonic anhydrase IV but not by intracellular carbonic anhydrase II. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21680735 | PubMed |
| 6 | 15772071 | Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15772071 | PubMed |
| 7 | 33320840 | Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. | J Clin Invest | 2021 | https://conductscience.org/library/papers/33320840 | PubMed |
| 8 | 36269753 | Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cells. | PLoS One | 2022 | https://conductscience.org/library/papers/36269753 | PubMed |
| 9 | 27765922 | G-protein-coupled receptor 81 promotes a malignant phenotype in breast cancer through angiogenic factor secretion. | Oncotarget | 2016 | https://conductscience.org/library/papers/27765922 | PubMed |
| 10 | 35820598 | 'Warburg effect' controls tumor growth, bacterial, viral infections and immunity - Genetic deconstruction and therapeutic perspectives. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/35820598 | PubMed |
| 11 | 36902470 | Ovarian Cancer and Glutamine Metabolism. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902470 | PubMed |
| 12 | 32017930 | Drp1 mediates high glucose-induced mitochondrial dysfunction and epithelial-mesenchymal transition in endometrial cancer cells. | Exp Cell Res | 2020 | https://conductscience.org/library/papers/32017930 | PubMed |
| 13 | 30227844 | Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment. | BMC Cancer | 2018 | https://conductscience.org/library/papers/30227844 | PubMed |
| 14 | 36050306 | Lactate metabolism in human health and disease. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/36050306 | PubMed |
| 15 | 32917658 | Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer. | Cancer Immunol Res | 2020 | https://conductscience.org/library/papers/32917658 | PubMed |
| 16 | 37207796 | Targeting lactate metabolism and immune interaction in breast tumor via protease-triggered delivery. | J Control Release | 2023 | https://conductscience.org/library/papers/37207796 | PubMed |
| 17 | 26414764 | Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. | Nat Immunol | 2015 | https://conductscience.org/library/papers/26414764 | PubMed |
| 18 | 30936474 | Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. | Nat Cell Biol | 2019 | https://conductscience.org/library/papers/30936474 | PubMed |
| 19 | 29719602 | Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer. | Oncotarget | 2018 | https://conductscience.org/library/papers/29719602 | PubMed |
| 20 | 26522146 | Cellular distributions of monocarboxylate transporters: a review. | Biomed Res | 2015 | https://conductscience.org/library/papers/26522146 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794927 | Beyond Tumor-Intrinsic STAT3: Integrating Metabolic and Immune Communication in the Tumor Microenvironment of Cervical, Ovarian, and Endometrial Cancers. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794927 | PubMed |
| 41897350 | Metformin-A Type 2 Diabetes Mellitus Drug-And Ovarian Cancer: Anticancer Mechanisms and Therapeutic Implications. | Biomolecules | 2026 | https://conductscience.org/library/papers/41897350 | PubMed |
| 41561760 | The application value of lactate dehydrogenase in gynecological malignant tumors. | Front Oncol | 2025 | https://conductscience.org/library/papers/41561760 | PubMed |
| 41555342 | ESM1 and protein lysine L-lactylation modification (Pan-kla) in ovarian cancer: coexpression, clinical significance, and prognostic value. | Diagn Pathol | 2026 | https://conductscience.org/library/papers/41555342 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40314877
GET https://conductscience.org/api/papers/v1/40314877/references?page=2